SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001790340-24-000064
Filing Date
2024-08-06
Accepted
2024-08-06 16:07:53
Documents
15
Period of Report
2024-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imrx-20240806.htm   iXBRL 8-K 24919
2 EX-99.1 imrx-20240806xexx991.htm EX-99.1 91356
6 imlogo.jpg GRAPHIC 6512
  Complete submission text file 0001790340-24-000064.txt   267530

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imrx-20240806.xsd EX-101.SCH 1926
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imrx-20240806_lab.xml EX-101.LAB 23705
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imrx-20240806_pre.xml EX-101.PRE 13601
17 EXTRACTED XBRL INSTANCE DOCUMENT imrx-20240806_htm.xml XML 2922
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40675 | Film No.: 241179211
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)